Skip to content
Single Family OfficePuts its own capital into companiesLAST VERIFIED Oct 2026 · 6 SOURCES

Elysia Capital

Also known as Elysia Capital S.r.l.

Turin investment company founded by Stefano Buono and Maribel Lopera Sierra, their family office per Elysia Productions; site lists investments from 2015 to 2021 (newcleo, D-Orbit).

USEFUL FOR Founders · Co-investors

Turin family office of Stefano Buono and Maribel Lopera Sierra. Not related to Elysian Capital (UK private equity).

Family & background

FAMILY
Buono / Lopera Sierra
WEALTH ORIGIN
Advanced Accelerator Applications (sold to Novartis)
HEADQUARTERS
Turin, Italy

Investment approach

SECTORS
HealthTechBiotech & Life SciencesDeep TechClimate & EnergySpaceFood & AgricultureMedia & EntertainmentEducation
GEOGRAPHY
Global
STAGES
SeedSeries ASeries B
ROUTES
Companies (own capital)
STRATEGIES
Direct investmentsVenture capitalImpact
INBOUND
Accepts submissions

Overview

Elysia Capital is a Turin-based investment company founded by entrepreneur Stefano Buono, founder of Advanced Accelerator Applications (sold to Novartis), and Maribel Lopera Sierra. The founders' Elysia Productions site describes it as the family office that Stefano Buono and his wife Maribel Lopera Sierra founded in 2018. It invests in projects in innovation, social impact, wellbeing, education, and art and culture in Italy, Europe, the US, Latin America and Asia. Its listed investments include newcleo, D-Orbit, GenomSys, Kither Biotech, Affera, LIFTT and Planet Smart City.

Holdings & investments (19)

  • newcleoNOTABLE
    Climate & Energy · since 2021
  • D-OrbitNOTABLE
    Space · since 2019
  • Microchannel Devices
    Deep Tech · since 2021
  • Elysia Productions
    Media & Entertainment · since 2021
  • LIFTT
    since 2020
  • Affera
    HealthTech · since 2020
  • Abeona Therapeutics
    Biotech & Life Sciences · since 2020
  • Massimo De Carlo (gallery)
    since 2020
  • GenomSys
    HealthTech · since 2019
  • Kither Biotech
    Biotech & Life Sciences · since 2019
  • EBAMed
    HealthTech · since 2019
  • Renovacor
    Biotech & Life Sciences · since 2019
  • Planet Smart City
    Real Estate & PropTech · since 2018
  • Qardio
    HealthTech · since 2018
  • Farmalisto
    HealthTech · since 2018
  • Sailogy
    Consumer & E-commerce · since 2018
  • Erbert
    Food & Agriculture · since 2018
  • Terabee
    Deep Tech · since 2016
  • Asia Strategic Holdings
    Education · since 2015

People

  • Stefano Buono
    Founder · source
  • Maribel Lopera Sierra
    Founder · source
  • Luca Alemani
    Managing Director Italy · source
  • Farhan Munir
    Managing Director UK · source

Frequently asked questions

Elysia Capital is a single family office based in Turin, Italy.

Elysia Capital invests on behalf of the Buono / Lopera Sierra family (Advanced Accelerator Applications (sold to Novartis)).

Elysia Capital invests its own capital into companies. Its stated asset mix includes direct investments, venture capital and impact.

Elysia Capital invests at Seed, Series A and Series B stages in HealthTech, Biotech & Life Sciences, Deep Tech, Climate & Energy, Space, Food & Agriculture, Media & Entertainment and Education.

Key people at Elysia Capital include Stefano Buono (Founder), Maribel Lopera Sierra (Founder), Luca Alemani (Managing Director Italy) and Farhan Munir (Managing Director UK).

Elysia Capital's holdings and investments include newcleo, D-Orbit, Microchannel Devices, Elysia Productions, LIFTT, Affera, Abeona Therapeutics and Massimo De Carlo (gallery), among others.

Elysia Capital states that it accepts submissions through its official contact page.